| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Co-chief Executive Officer | Director, 10% Owner | Chief Executive Officer +1 more
2 companies
Duggan Robert W is a Co-chief Executive Officer at Summit Therapeutics Inc. with holdings across 2 companies. Recent SEC Form 4 filings include 13 buys and 0 sells.
Estimated insider holdings value: $11214.2M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 6, 2023 | PLSE Pulse Biosciences, Inc. | Director, 10% Owner | Buy | 82,813 | $9.06 | $750,285.78 | +0.2% | +1.8% | +108.2% | |
| Dec 5, 2023 | PLSE Pulse Biosciences, Inc. | Director, 10% Owner | Buy | 66,021 | $9.34 | $616,636.14 | +23.1% | +2.8% | +110.4% | |
| Dec 4, 2023 | PLSE Pulse Biosciences, Inc. | Director, 10% Owner | Buy | 27,000 | $10.38 | $280,260.00 | +10.4% | -5.9% | +97.5% | |
| Dec 1, 2023 | PLSE Pulse Biosciences, Inc. | Director, 10% Owner | Buy | 45,600 | $9.07 | $413,592.00 | +21.4% | +7.9% | +133.6% | |
| Nov 30, 2023 | PLSE Pulse Biosciences, Inc. | Director, 10% Owner | Buy | 152,944 | $9.06 | $1,385,672.64 | +254.9% | +12.5% | +137.0% | |
| Nov 29, 2023 | PLSE Pulse Biosciences, Inc. | Director, 10% Owner | Buy | 218,600 | $9.38 | $2,049,784.00 | +0.6% | +17.7% | +131.6% | |
| Nov 28, 2023 | PLSE Pulse Biosciences, Inc. | Director, 10% Owner | Buy | 124,397 | $8.98 | $1,117,085.06 | +0.3% | +13.6% | +133.1% | |
| Nov 17, 2023 | PLSE Pulse Biosciences, Inc. | Director, 10% Owner | Buy | 20,241 | $6.10 | $123,470.10 | - | +50.3% | +171.9% | |
| May 9, 2023 | PLSE Pulse Biosciences, Inc. | Director, 10% Owner | Buy | 10,022,937 | $6.51 | $65,249,319.87 | +49.2% | -11.3% | -14.2% | |
| Mar 6, 2023 | SMMT Summit Therapeutics Inc. | Chief Executive Officer | Buy | 376,489,880 | $1.05 | $395,314,374.00 | +214.1% | +33.8% | +264.7% |